network signatures of igg immune repertoires in hepatitis

1Scientific RepoRts | 6:26556 | DOI: 10.1038/srep26556

www.nature.com/scientificreports

Network Signatures of IgG Immune Repertoires in Hepatitis B Associated Chronic Infection and Vaccination ResponsesYa-Hui Chang1,*, Hui-Chung Kuan2,*, T. C. Hsieh3, K. H. Ma3, Chung-Hsiang Yang1, Wei-Bin Hsu1,†, Shih-Feng Tsai1, Anne Chao3 & Hong-Hsing Liu1,2

The repertoire of IgG antibody responses to infection and vaccination varies depending on the characteristics of the immunogen and the ability of the host to mount a protective immune response. Chronic hepatitis B virus (HBV) infections are marked by persistent infection and immune tolerance to vaccination. This disease offers a unique opportunity to discover key repertoire signatures during infection and in response to vaccination. Complementarity determining region 3 of an antibody heavy chain (CDR-H3) has a major impact on the antigenic specificity of an antibody. We used next-generation sequencing to characterize the CDR-H3 sequences in paired siblings of 4 families in which only one member of each pair had chronic HBV infection. Blood samples were obtained before and 2 weeks after HBV vaccination. The analysis revealed a huge network of sequence-related CDR-H3 clones found almost exclusively among carriers. In contrast, vaccination induced significant increases of CDR-H3 cluster diversities among siblings without hepatitis B. Several vaccination-associated clone clusters were identified. Similar findings of vaccination-associated clone networks were observed in healthy adults receiving HBV boosters. These strategies can be used to identify signatures of other infectious diseases and accelerate discoveries of antibody sequences with important biomedical implications.

The repertoire of IgG antibody responses to infection and vaccination varies depending on the nature of the immunogen and the ability of the host to mount a protective immune response. It is now known that there are huge variations in immune repertoires even between identical twins1. Sensitive and specific methods are needed to delineate these immune repertoires to better understand immune responses in the coming era of personalized medicine. People with chronic hepatitis B virus (HBV) infections are at high risk of developing hepatitis, hepatic cirrhosis and hepatocarcinoma2. Their clinical status and prognosis is currently defined by a variety of antibody responses. For example antibodies against core antigen (HBcAg) are hallmarks of past exposure to the virus3, and appearance of immunoglobulins against e-antigen (HBeAg) represents a stage shift for hepatitis B carriers3. Vaccines based on the s-antigen (HBsAg) are the most effective method to prevent chronic infections and associ-ated liver diseases4. However, HBsAg vaccines are ineffective in HBV carriers because of virus-induced immune tolerance5. These distinct features of chronic HBV infections stimulated us to explore the IgG immune repertoire of HBV infections and response to immunization as a model to develop an immune repertoire-based approach to infection and vaccination.

Prior to the current era of next-generation sequencing (NGS)6 antibody responses could only be characterized at low resolutions by either cloning or spectratyping. Because nucleotides in the complementarity-determining region 3 of the heavy chain (CDR-H3) on most antibodies are sufficient to determine specificities7, sequence repertoires of this region can effectively serve as clone proxies of humoral immunity. Nucleotides flanking the CDR-H3 region are relatively constant and have been characterized with standardized numbering8. Appropriately designed PCR primers could adequately prepare CDR-H3-based immune repertoires for parallel sequencing.

1Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan 35053, Taiwan. 2Pediatrics, En Chu Kong Hospital, Sanxia 23702, Taiwan. 3Institute of Statistics, National Tsing Hua University, Hsin-Chu 30043, Taiwan. †Present address: Department of Orthopedic Surgery, Chang Gung Memorial Hospital at Chia Yi, Puzih City 61363, Taiwan.*These authors contributed equally to this work. Correspondence and requests for materials should be addressed to H.-H.L. (email: [email protected])

received: 21 October 2015

accepted: 05 May 2016

Published: 25 May 2016

OPEN

mailto:[email protected]

www.nature.com/scientificreports/


Consequently biological conditions can be defined in terms of immune repertoires at clonal resolutions. This helps to address questions from a numerical approach.

Many investigations adopting NGS-profiled B-cell immune repertoires have provided detailed insights in response to vaccination. For example the lineage structure of responding antibodies has been demonstrated for influenza vaccines9. A twin study revealed the stochastic or individual-specific effects on clone selections against acute antigenic stimuli from live-attenuated chickenpox1. A study involving multiple time points after HBV vac-cination revealed sequence convergence mostly notable at 14 and 21 days later10. The dynamics of influenza vaccination were recently defined without the need for cell sorting11. Acute dengue fever was found to carry a convergent antibody signature12, but disturbances to immune repertoires from chronic infections remained elusive. A study of human immunodeficiency virus-1 (HIV-1) infections found skewed selections of antibody heavy chain families13. Finally, investigations of the repertoires of adults carrying cytomegalovirus (CMV) or Epstein-Barr virus (EBV) disclosed a few individualized phylogenetic trees without clear associations with either virus14.

In the current study we used next-generation sequencing to characterize the CDR-H3 sequences in paired siblings of 4 families in which only one member of each pair had chronic HBV infection. Blood samples were obtained before and 2 weeks after HBV vaccination. Analyses were performed with abundance-weighted heu-ristics of clonal transcripts under the assumption that amounts of clonal transcripts positively correlate with functional dominance of corresponding cells. For example plasma cells have very high amounts of clonal tran-scripts15 and numbers of related memory cells increase nearly to a hundred fold after vaccination10, both of which can be essentially described with abundance-weighted heuristics of clonal transcripts. The analysis revealed a huge network of sequence-related CDR-H3 clones found almost exclusively among carriers. In contrast, vacci-nation induced significant increases of CDR-H3 cluster diversities among siblings without hepatitis B. Several vaccination-associated clone clusters were identified. Similar findings of vaccination-associated clone networks were observed in healthy adults receiving HBV boosters.

ResultsStudies of sibling pairs with and without chronic hepatitis B and response to vaccination. Four pairs of children born to HBeAg positive mothers were recruited from four different families (Table 1). In each family one child was an HBeAg carrier while the other was an HBsAg negative non-carrier. Liver-related serum transaminases were normal in both. The last dose of HBV vaccine had been administered at least two years after they were vaccinated at 6 months old as part of the national vaccination program. Blood samples were collected

Symbol Family Carrier Vaccinated Read # Clone # Age Sex

F1Cpre 1 Y N 2,396,273 218,635 13 F

F1Cpost 1 Y Y 2,343,662 117,953 – –

F1NCpre 1 N N 2,905,928 159,348 11 M

F1NCpost 1 N Y 2,562,822 185,642 – –

F2NCpre 2 N N 3,025,044 240,809 14 M

F2NCpost 2 N Y 2,083,647 165,250 – –

F2Cpre 2 Y N 2,761,308 177,760 12 F

F2Cpost 2 Y Y 2,308,574 111,368 – –

F3Cpre 3 Y N 2,629,391 138,275 10 M

F3Cpost 3 Y Y 1,483,239 93,570 – –

F3NCpre 3 N N 1,409,905 128,753 4 F

F3NCpost 3 N Y 1,721,008 99,387 – –

F4NCpre 4 N N 2,240,377 189,501 5 M

F4NCpost 4 N Y 1,702,443 122,475 – –

F4Cpre 4 Y N 1,545,189 159,415 3 F

F4Cpost 4 Y Y 1,670,657 182,713 – –

A1pre – N N 1,548,623 59,456 42 F

A1week1 – – 1 week 1,655,284 61,541 – –

A1week2 – – 2 weeks 1,268,812 52,285 – –

A2pre – N N 1,569,305 71,311 35 F

A2week1 – – 1 week 1,108,712 49,262 – –

A2week2 – – 2 weeks 2,473,612 75,467 – –

A3pre – N N 960,640 34,528 47 F

A3week1 – – 1 week 1,039,772 44,543 – –

A3week2 – – 2 weeks 1,214,046 35,924 – –

A4pre – N N 952,577 35,765 37 F

A4week1 – – 1 week 1,221,307 56,213 – –

A4week2 – – 2 weeks 913,435 44,986 – –

Table 1. Basic profiles of subjects and samples.



immediately before and 2 weeks after vaccination (Supplementary Fig. S1A). Anti-HBs antibodies for non-car-riers were positive at either 6-month to 1-year of follow-up (family 1, 2, and 4) or before vaccination (family 3). Anti-HBs antibodies were not present in carriers as expected5. IgG repertoires of CDR-H3 were prepared from reverse-transcribed total RNA plus 2 runs of optimized PCR (Supplementary Fig. S1B and Supplementary Table 1). The underlying logic is that there is a positive correlation between the amounts of clonal transcripts and func-tional dominance of corresponding cells15. Examples include plasma cells that contain very high amounts of clonal transcripts15 and functionally related memory cells whose numbers can increase up to a hundred fold after vaccination10. Both conditions can be conceptually unified in terms of counts of related clones, or abun-dance-weighted heuristics. Raw reads from NextSeq 500 (Illumina, USA) were processed with both open-domain utilities and homemade Python scripts (Supplementary Fig. S1C). CDR-H3 in amino acids based on IMGT defi-nitions8 was extracted for downstream analyses. Throughputs per sample in average were 2.2 ± 0.5 (SD) million reads belonging to 155.7 ± 42.5 (SD) thousand unique CDR-H3 clones (Table 1).

Immune repertoires exhibited similar length distributions and amino acid compositions but could be distinguished from each other. Lengths of IgG CDR-H3 immune repertoires were similarly distributed for all children in a bell shape manner with few spikes (Fig. 1A). The mean lengths for carriers and non-carriers were precisely identical at 13.2 ± 0.0 (SE) amino acids. This was a little shorter than averaged from the database16. The difference might be explained by the nature of the younger population since CDR-H3 lengths tend to be longer in the elderly14. The mean length was found to be longer in adults recruited for the second part study (see below). The top two longest CDR-H3 clones contained 56 and 55 amino acids, respectively. They were identified from the 14-year-old non-carrier in the 2nd family, who also was the oldest child (Table 1). The 5-year-old non-carrier in the 4th family also had two CDR-H3 clones with 54 amino acids.

Compositions of amino acids among all 16 IgG CDR-H3 immune repertoires exhibited very high similarities (Fig. 1B). The most frequently used 6 amino acids were Tyr, Asp, Gly, Ala, Arg, and Ser for all repertoires. These are exactly the same as reported previously16. We further assayed mutual resemblances of the repertoire pairs using the Morisita index17. This places greater emphasis on more abundant clones (Supplementary Table 2). The results revealed very high variations independent of sibling relationships. There were few common clones with indices up to 0.997~0.999. Differences between pre- and post-vaccination samples from the same individual were lower. However there were still significant dissimilarities among either the carrier (0.955 ± 0.004, SD) or the non-carrier groups (0.945 ± 0.038, SD). In summary, IgG CDR-H3 immune repertoires were distinct in clonal contents, but were similar in length and amino acid compositions regardless of the HBV status.

Carriers resembled each other in the principal component analysis. IgG immune repertoires were represented as Hellinger-transformed18 vectors comprising normalized reads of 2,427,148 unique CDR-H3

Figure 1. Distributions of CDR-H3 lengths and amino acid compositions. (A) CDR-H3 lengths were distributed as bell shaped curves regardless of HBV infection or vaccination. Mean lengths for both carrier and non-carrier children were identical at 13.2 ± 0.0 (SE) amino acids. (B) Composition of the amino acids resembled each other regardless of the clinical condition or vaccination. The most frequent amino acids in all samples were tyrosine, asparagine, glycine, alanine, arginine, and serine.



clones. Principal component analysis (PCA)19 effectively reduced millions of dimensions to two components. The discernible implications are that carriers appear to be grouped together but non-carriers are distant from each other (Fig. 2A). Notably, siblings were not closer to each other than unrelated children and vaccination induced little perturbation to PCA projections. Samples from the same individual were always closely aligned. Although the first two components of PCA explained only 7.9% and 7.7% variations in the dataset, this was sufficient to reveal hidden relationships among children with chronic hepatitis B infections, as evidenced by positive values of component 2 for carriers in all.

Abundant clones discriminated carriers from non-carriers. The top CDR-H3 clones with the highest absolute loading values in the two components of PCA were further evaluated. Reads belonging to these clones occupied a significant portion in the dataset (Fig. 2B). For example, among 952 unique clones pooled from the leading 500 clones in the two PCA components, 9 out of 16 samples already contributed more than 10% of reads to this set of clones. As unique clones were increased to 3,650, they corresponded to only 0.15% of all clones. However more than one-tenth of the reads in all repertoires, except one, could be ascribed to this clone pool. One carrier and two non-carriers had repertoires over half of which had reads that belonged to these abundant clones. It is likely that many of the rare clones could be discarded without compromising the discriminating capabilities of PCA.

Component analyses were accordingly repeated with different percentages of abundant clones (Fig. 2C). The top 10% were suboptimal to distinguish carriers from non-carriers. The resolutions were improved with higher percentages at either 20% or 25%. The trailing 80% of rare clones failed to distinguish repertoires from children with HBV infections. Accordingly, the role of the most abundant 20% of the clones requires further study.

Biased clones prevailed in carriers. The top 20% of the clones consisted of 481,543 unique sequences. Most were only detected in one child’s pooled repertoire combined from both pre- and post-vaccination samples (Table 2). Among the clones that appeared in two children’s repertoires, fewer than expected were shared by carriers and non-carriers (p < 0.001 in binomial test). A similar observation was also noted for clones with 3 or 4 incidences (p < 0.001 in binomial test). These phenomena could be due to analogous humoral immune reac-tions only in carriers such that reactive clones make exclusive appearance from non-carriers. Because CDR-H3 sequences with indel-free Hamming distance 1 could be related biologically9,12,20,21, a heuristic to efficiently exam-ine the hypothesis of humoral analogy was to cluster CDR-H3 clones with the above Hamming distance crite-rion. An exhaustive search for connections among the 2-incidence 8,502 clones in carriers and 11,158 clones in non-carriers identified 7,129 and 9,560 independent clusters, respectively.

Under the hypothesis that clusters with more members could be more biologically relevant, the top 0.5% clus-ters in ranks of member counts from either group were included for feature selections with both linear support vector classification (SVC) and logistic regression (LR) regularized with “l1” penalties in the scikit-learn pack-age22 to best categorize infection statuses. The penalty parameters were chosen by minimizing the error rates of 8-fold cross validations to 0.0625 (Supplementary Fig. 2). Out of the 35 clusters in carriers and the 47 clusters in non-carriers, the top 27-member cluster in the infected group was highly supported by both SVC and LR models (Fig. 3A,B). Only 4 clusters in the carriers and 1 cluster in the non-carriers were otherwise weakly supported.

In view of the long duration of chronic infection and iterative nature of B cell immune reactions, we expected that there would be more carrier-associated clones. Based upon the distance heuristic describe above, an addi-tional 195 out of the remaining 481,516 abundant sequences were found within the reach of one Hamming dis-tance. As expected nearly all additional clones belonged to the carrier group rather than the non-carrier group (Fig. 3C). These related sequences contributed 0.1–0.3% reads to the IgG immune repertoires of all carriers in at least one sample (Fig. 3D). The near absence of the huge clone web among non-carriers implied that these con-nected CDR-H3 sequences provided a remarkable signature of chronic infection in hepatitis B carrier children.

Vaccination differentially affected diversity of immune repertoires. Different impacts to the diver-sities of CDR-H3 clones were expected with vaccination in non-carriers versus carriers because of immune tol-erance5. To establish a fair base for comparisons of clone diversities between IgG immune repertoires, random rarefactions were applied to the dataset to normalize sequence reads for all repertoires. Clones were stratified by the base 2 logarithm of reads into 18 orders such that clones with similar functional importance would be grouped together15. Clone counts in each order were averaged after 10 rounds of rarefactions (Fig. 4).

We found that orders higher than 2 contained the most abundant 20% of the clones. These exhibited different effects following vaccination (Fig. 4A,B). The post-vaccination repertoires of all the children with chronic HBV infections showed a slight decrease in counts of clones ranked in order 3 or higher, but most of the healthy siblings exhibited an increase (− 0.90 ± 0.24 vs. 1.32 ± 1.03 % SE, p < 0.05 in Student’s t-test, Fig. 4B).

Diversities of clones in each order were further characterized in two steps: clusters were constructed first by connecting sequences with indel-free Hamming distance 1 and were subsequently profiled with Hill numbers23 for all rarefaction datasets (Supplementary Fig. 3). Post-vaccination effects were categorized according to the curve shifts of Hill numbers with parameter 2 and above such that the most frequent clusters had greater diversity measurements (Supplementary Table 3). Among order 3–10 which constituted the majority of the top one-fifth of clones non-carriers had order 3, 4, 5, and 10 with positive shifts but carriers had only order 9 with such a positive trend (Fig. 4C). Because both carriers and non-carriers reacted similarly in order 11–15 and few clusters existed in order 16–18, vaccination-associated clusters would be less likely present among these orders. Instead differen-tial influences by vaccination were mainly suspected in the five mid-abundance orders exhibiting overall tolerant behaviors with less diversity expansions in carriers’ immune repertoires.

Increases in diversity measurements could result from amplification of pre-existing clones before vaccination or alternatively from contributions of new clones freshly appearing after vaccination. In order to differentiate



Figure 2. Principal component analysis of IgG immune repertoires. (A) Samples from carriers were grouped together. Non-carriers were shown separately. Open circles denote repertoires before vaccination. Solid triangles denote those after vaccination. Repertoires from the same individual were always close to each other, but repertoires between siblings were distant. (B) Clones that contributed most to the principal component analysis were also the most abundant. Among the top 500 clones from both components over half of the 16 samples consisted of more than 10% of reads for these sequences. The most significant 3,650 unique CDR-H3s, which comprised merely 0.15% of all clones, trended to accumulate more than one-tenth of reads for every repertoire except one. Over half of the reads of five samples were accountable by these supporting sequences. (C) The most abundant 10% of clones were suboptimal in grouping the carrier samples (dotted oval). However the most abundant 20% or 25% of the clones could clearly distinguish the carriers. The trailing 20–100% of clones failed to differentiate the repertoires of carriers from non-carriers.



these two possibilities, the percentages of new clones in post-vaccination CDR-H3 clusters belonging to the five mid-abundance orders were determined (Fig. 4D). Clearly the positive momenta were driven by the presence of new clones such that non-carriers had higher percentages in order 3, 4, and 5 but lower percentages in order

Incidences Total Clone # Carrier Alone Non-carrier Alone

Both

p-Value* Data Model

1 out of 8 458,171 222,661 235,510 0 0 1.00

2 out of 8 22,250 8,502 11,158 2,590 12,715 < 0.001

3 out of 8 973 78 241 654 834 < 0.001

4 out of 8 119 1 11 107 116 < 0.001

5–8 out of 8 30 0 0 30 30 1.00

Table 2. Distributions of abundant clones among carriers and non-carriers. * p-Value was calculated with binomial tests.

Figure 3. CDR-H3 cluster among carrier children. (A,B) A single 27-member cluster was identified from carrier 2-occurrence clones. This cluster was best associated with HBV-infection. Vertices in the graph represent CDR-H3 clones, and connecting edges equal in indel-free Hamming distance 1. (C) The 27-member cluster was extended by indel-free Hamming distance 1 to connect other similar sequences among the most abundant 20% of clones. This resolved into a new 222-member cluster. Most members were restricted to carriers only, as depicted in solid circles. (D) The extended cluster appeared mostly in the carrier children. Each child had at least one repertoire that contributed more than 0.1% of reads to the connected web.



Figure 4. Changes in clonal diversity with vaccination. (A) Clone counts in order 3 or higher decreased after vaccination for all the carriers. In contrast, they tended to increase among the non-carriers. The results are shown as the average of 10 rarefactions. (B) There was about a 1% decrease of clone counts in order 3 or higher for carriers. This was universal for all rarefaction datasets. This tendency was instead increased for most non-carriers. Error bars show the standard errors, Student’s t-test p < 0.05. (C) Diversities of CDR-H3 clusters connected with indel-free Hamming distance 1 in each order were profiled in Hill numbers. Vaccination-induced trends with parameter 2 or above distinguished carriers from non-carriers within order 3, 4, 5, 9, and 10. In order 9 carriers exhibited a positive shift after vaccination. However non-carriers had increased diversities in order 3, 4, 5, and 10. A typical result is shown from one rarefaction dataset. (D) Percentages of new clones in post-vaccination CDR-H3 clusters belonging to the five mid-abundance orders were calculated. Non-carriers had a significantly higher percentage in order 3, 4, and 5. Carriers had more new clones in order 9 (p < 0.0001 in Student’s t-Test for all rarefactions). The difference in order 10 was insignificant. The greatest contrast was noted for order 5.



9 (p < 0.00005 in Student’s t-Test for all rarefactions). The most conspicuous difference was located in order 5, where a nearly 10% margin was led by non-carrier children. Inequality in order 10 did not reach statistical signif-icance in any of the rarefaction datasets.

Vaccination-responding clusters manifested in order 5. The contradictory effects on CDR-H3 diver-sities as demonstrated in order 3, 4, 5, 9, and 10 among IgG immune repertoires could increase the odds to dis-cover sequences that correlated with specific vaccination responses. Therefore the top 0.5% clusters in ranks of clone counts were tested with both linear SVC and LR models regularized with “l1” penalties to best recognize post-inoculation repertoires in non-carriers. The penalty parameters were chosen by minimizing the error rates after 8-fold cross validations. We found that SVC and LR models for order 3, 4, 9, and 10 disagreed considerably with each other for clusters that best distinguished the post-vaccination repertoires in non-carriers. On the other hand for order 5 the LR models consistently demonstrated the top-ranked 4 clusters by SVC models, but failed to support any of the other candidates (Supplementary Table 4). The significance of these observations was tested with random label permutations for 10,000 runs in each rarefaction. We found that the chance of 4 or more clus-ters with simultaneous strong support by both models was less than 0.02. The candidate clusters always belonged to those with abundant member clones. None of the clusters that exceeded 0.3% in ranks received nonzero coef-ficients in either SVC or LR selections (Supplementary Table 4).

Detailed analyses of the dominant candidates in SVC models demonstrated essentially 6 independent clusters out of 10 rarefaction datasets (Supplementary Table 5). Five of the 6 connected graphs presented as bursting stars with the highest PageRank24 vertex located at the center mimicking iterative activities from a prototype clone (Fig. 5A). The clusters constructed from rarefactions were extended by incorporating clones within indel-free Hamming distance 1 reach from the original dataset. To further test the specificity of these constructed clusters, a second outreach to include even another one indel-free Hamming-distanced clones was performed. This exhaus-tive search increased clone counts of clusters to 479, 346, 436, 705, 294, and 849, respectively (Supplementary Fig. S4A). Percentage reads of the six extended clusters correspondingly rose to 0.5% to 3% in post-vaccination repertoires among non-carriers only. Their pre-vaccination samples had fairly low levels of these clones instead (Fig. 5B). Two non-carriers responded polyclonally; there were two clusters at comparable levels. This observation demonstrated the stochastic nature of rarefactions in the analytic framework.

Analysis of clusters among adults following a booster vaccination. Identical vaccination- responding clusters could be discovered by SVC and LR feature selections without contributions from carriers’ clones in order 5 (data not shown). This made it reasonable to use the analyses scheme for other scenarios as well. To test this possibility, we established a new dataset by collecting samples from 4 healthy adults receiving HBV vaccine boosters (Supplementary Fig. S1A). Each adult had 3 repertoire libraries from 3 time points at prior to, 1-week and 2-weeks after vaccination (Table 1). We found that adults 2, 3, and 4 already had baseline anti-HBs antibodies above the detection threshold. Adult 1 achieved a positive serologic response only after receiving the booster. The libraries were processed through the same pipeline (Supplementary Fig. S1C). The mean length of CDR-H3 was 14.7 ± 0.1 (SE) amino acids. This was longer than in children, as expected (see above).

Ten rarefaction datasets were prepared for downstream analyses. In the Hill number plots (Supplementary Fig. 5), the baseline counts of unique clones were much higher than those from post-vaccination samples. The obser-vations were illustrated as Hill numbers with parameters approximating zero (see methods). For order 5 most of the 2-week samples exhibited an upward trend as compared to baseline. The same strategy with SVC and LR feature selections depending on the baseline and 2-week repertoires was applied to order 5 clones (Supplementary Table 6), not including the 1-week data. Nine clusters with member counts of 39, 26, 29, 163, 38, 21, 86, 85, and 8 were identified (Fig. 6A and Supplementary Table 7). A similar 2-step indel-free Hamming distance 1 extension as performed for the 6 clusters in Fig. 5B was done to exhaustedly incorporate related clones from the complete adult dataset (Supplementary Fig. S4B). This increased the member counts of the 9 clusters to 529, 327, 523, 2577, 345, 286, 1474, 1144, and 166, respectively. We found that most adults responded polyclonally at 2 weeks after vaccine boosters. This enriched the read percentages up to 16% in the repertoires (Fig. 6B). The 3-cluster profile for adult 4 at week 2 was the same as that for adult 2 and 3 at baseline. Adults 2 and 3 responded to vaccination with new clusters (Fig. 6B). Although clusters were selected independent of 1-week data, corresponding reads were already increased at that time point for indicated adults (Fig. 6B). The gradual enrichment of these clusters implied specific roles they played in response to vaccination. The significance was further addressed using the Spearman rank test for each cluster in terms of read percentages. This collectively reached a p-value of 0.03 with Bonferroni corrections for multiple comparisons.

DiscussionEffective methods to extract relevant sequences out of CDR-H3 repertoires in response to vaccination would be of great clinical value. Many investigators, in recent years, have addressed this challenge by use of high-throughput sequencing. This is not a simple task because there can be 1011 or higher possible receptor sequences among B cells25. One strategy to increase the sensitivity and specificity is to pool related clones into clusters that are func-tionally related9,12,20,21. It is now known that sequence similarities among plasmablasts at one week after vaccina-tion are very limited, even between identical twins1. The most notable sequence convergence occurs at 2–3 weeks after vaccination from memory B cells10. The number of corresponding memory cells can rise up to a hundred fold above baseline at these time points10. This would justify a simple heuristic to use abundance sums of related clones at 2 weeks after vaccination to discover the optimum CDR-H3 signals (Supplementary Fig. S1A).

In the current study we identified 6 clusters in children following HBV vaccination (Fig. 5A). None of the clusters were shared among individuals, but two of children appeared to react simultaneously with two clusters



(Fig. 5B). Similarly 3 out of 4 adults responded with more than one cluster at 2 weeks after vaccination (Fig. 6B), but none shared the same cluster. Prior investigators have found limited similarities of CDR-H3 sequences after vaccination. For example, specific sequences against tetanus toxoids can be categorized into at least 9 groups10; responding sequences after repeated HBV vaccination could be different as well26. Because of our small sample size we did not expect to find convergence of reacting clusters. However the 3-cluster profile from adult 4 was also present at baseline for adult 2 and 3 (Fig. 6B). Both of these subjects were known to have significant amounts of antibodies against HBsAg before receiving the boosters. We suspect that these clusters could belong to the same group of protective antibodies. Further functional verification would be required.

One large set of connected CDR-H3 clones was identified in HBV carriers (Fig. 3C). The clone network belonged to the most abundant subset of IgG repertoires, implying that the continuous presence of HBV might cause a persistent expansion of related CDR-H3 sequences. It is known whether antibodies against HBcAg are a hallmark of prior HBV exposure3. Therefore the relationship of this clone cluster with anti-HBc antibodies is worthy of further investigation. In this study we did not attempt to associate CDR-H3 sequences with antibodies against HBeAg. In view of the essential role of such antibodies to produce a stage shift for hepatitis B carriers (e conversion)3, it would be of interest to compare IgG repertoires both before and after e conversions.

Hill numbers23 have been widely used to evaluate ecological diversities. In the current study we adapted the formula by comparing CDR-H3 clusters to ecological species. Differences were detected in Hill numbers between

Figure 5. CDR-H3 clusters associated with vaccination in non-carrier children. (A) Six CDR-H3 clusters in order 5 were selected by both linear support vector classification and logistic regression. An open circle marks the clone with the highest PageRank score. The corresponding sequence, listed below, was connected to other similar clones with an indel-free Hamming distance of 1. (B) The six clusters were further extended with two rounds of Hamming distance 1 as described in the text. Percentages of the reads belonging to the new clusters rose significantly in post-vaccination samples only in the non-carriers. In family 1 and 4 there were two amplified clusters. There was only one new cluster in family 2 and 3. Vaccination was associated with at least a 0.5% increase in cluster reads for all non-carrier children.


1 0Scientific RepoRts | 6:26556 | DOI: 10.1038/srep26556

carrier and non-carrier children in relation to vaccination responses (Fig. 4C). Greiff et al. independently found that Hill numbers were applicable to assay immune repertoires under various clinical conditions27. Our findings were based on clusters among sorted orders of individual clones, allowing more focused linkage to clinical status. When parameters are set to zero, Hill numbers provide counts of cluster numbers. We found that the baseline

Figure 6. CDR-H3 clusters associated with vaccine boosters among healthy adults. (A) Nine CDR-H3 clusters in order 5 were selected by both linear support vector classification and logistic regression. The clone in the open circle had the highest PageRank score. The corresponding sequence is listed below. All clones were connected to similar clones with an indel-free Hamming distance of 1. (B) A two-step extension by Hamming distance 1 for the nine clusters was performed as described in the text. Read percentages of the new clusters rose significantly at 2 weeks following vaccination and were detectable for the indicated individuals at 1 week following the booster. All except adult 3 reacted with more than one clone network. None of the adults shared clusters even though the 3-cluster profile from adult 4 was also present at baseline for adults 2 and 3.



counts in adults were always much higher than those in post-vaccination samples (Supplementary Fig. 5). However this was not the case for children (Supplementary Fig. 3). The difference between children and adults might be explained by a more diversified clone profile in an age-related IgG repertoire baseline and a more active expansion of memory B cells in response to vaccination. This notion is supported by both the higher read per-centages of reacting clusters and a much more complex plots of clone networks in Fig. 6.

MethodsEthics, consent and permissions. All experimental protocols were approved by both the Institutional Review Board of National Health Research Institutes and the Institutional Review Board of En Chu Kong Hospital. Study methods were carried out in accordance with the relevant guidelines. Informed consents were obtained from all subjects.

Case enrollment and blood sampling. For the first part of study in children, HBeAg positive carrier and HBsAg negative non-carrier siblings born to an HBeAg positive mother were enrolled from 4 families (Table 1). None of the children had active hepatitis. Each received a 1 ml intramuscular injection of ENERGIX-B (GlaxoSmithKline, UK). Two blood samples of 2.5 ml each were collected into PAXgene Blood RNA tubes (PreAnalytiX, CH) before and 2 weeks after vaccination (Supplementary Fig. S1A), respectively. Tubes were kept at room temperature for at least 2 hours before RNA extraction or − 80 °C storage. In the second part of study 2.5 ml whole blood was collected from four healthy adults at baseline and at 1 and 2-weeks after vaccination (Supplementary Fig. S1A). Specimens were processed in the same manner as for children.

Software and hardware. Software packages including PEAR28, Python29, Numpy & SciPy30, IPython31, scikit-learn22, Pandas32, Matplotlib33, PyOpenCL34, and igraph35 were deployed on a 2013 Mac Pro equipped with 3.7 GHz Quad-Core Intel Xeon E5, 64 GB memory, and two AMD FirePro D700 6 GB graphics cards.

Preparation of IgG immune repertoire for next generation sequencing. The experimental proce-dures were summarized in Supplementary Fig. S1B. Total RNA was extracted with PAXgene Blood miRNA Kit (QIAGEN). 1.2 μ g was reverse-transcribed with an IgG constant region specific primer (Supplementary Table 1) with SuperScript III Reverse Transcriptase and RNaseOUT (Life Technologies), going through 65 °C 5 min, on ice at least 1 min, 55 °C 60 min, and final 70 °C 15 min.

Normalized cDNA were multiplex amplified with a set of forward V-primers from known IgG alleles36 that were Primer 337 optimized by the same parameters and two reversed primers (Supplementary Table 1). All for-ward primers shared similar amplification efficiencies with linear correlations to cDNA concentrations across 5 logs and had low backgrounds as well as specific products in pilot optimizations. The reaction condition was 98 °C 2 min, 15 cycles of 98 °C 80 sec + 60 °C 60 sec + 65 °C 30 sec, 10 cycles of 94 °C 30 sec + 65 °C 90 sec, and final 65 °C 5 min with AccuPrime Taq DNA Polymerase High Fidelity (Life Technologies).

The product was amplified in a second PCR by the same polymerase with double-indexed P5 and P7 primers38 (Supplementary Table 1) under the condition 94 °C 2 min, 10 cycles of 94 °C 30 sec + 60 °C 30 sec + 68 °C 40 sec, 10 cycles of 94 °C 30 sec + 72 °C 90 sec, and final 72 °C 5 min. Products were sieved by 2% agarose gel under 30 V x 8 hours or 60 V × 4 hours and the target bands around 300 bp were eluted with MinElute Gel Extraction Kit (QIAGEN) before 150 bp paired-end sequencing (NextSeq, Illumina, USA). Raw reads were deposited to European Nucleotide Archive under the accession number PRJEB9332 [ENA: PRJEB9332].

Immune repertoire in amino acids. Demultiplexed raw sequences were processed in Python as outlined in Supplementary Fig. S1C. Briefly, sequences were paired with PEAR28; poor quality reads were removed at this step with default parameters, including a Phred filter score at 33. Reads must have no unknown ‘N’ nucleotides as well as matched end sequences on both 5′ and 3′ terminals to the amplifying primers. The expected CDR-H3 region as implicated by matched V-primers had to contain multiplicities of three nucleotides without stop codons. The N-end of translated amino acids from position 100–C104 had to align well to anticipated sequences as sug-gested by matched V-primers and the C-end had to have the W118 as well as the following GXG signatures, where X denotes any amino acids8. At last CDR-H3 without the minimal length of 2 amino acids were discarded. In average 53.8 ± 3.8% and 44.8 ± 4.4% (SD) of raw sequences in children’s and adults’ datasets, respectively, passed the above criteria.

Morisita index. For repertoire A and B with clone normalized frequencies FA and FB, the Morisita dissimilar-ity index17 is a measure to quantify the distance between two sets of clone sequences. This measure is dominated mainly by abundant clones; relatively rare clones have little effect, even if there are many of them. The measure (M) was calculated as

= − ∑∑ + ∑

M F FF F

1 2 ( )(1)

A B

A B2 2

Principal component analysis with immune repertoires as transformed clone percentages. There were overall 2,427,148 unique CDR-H3 clones from all 16 children’s samples. The normalized clone fre-quencies for each sample were Hellinger transformed18 before principal component analysis19 in SciPy. Clones in each repertoire were sorted by read frequencies and the top percentages of abundant clones were identified accordingly.



Binomial tests for biased clone prevalence. Given 4 carriers and 4 non-carriers, the combinatorial probability for one clone to belong to both groups is calculated with Binomial cumulative tests as

− ∈( ) ( )n n n1 2 4 / 8 , {1, 2, 3, 4} (2)

Rarefaction and cluster identification. Samples with more reads were randomly resampled with Python to match the repertoire with minimal read counts in the indicated dataset (Table 1). Rarefactions were per-formed 10 times and saved for downstream analyses. Clusters were identified in two steps. Indel-free Hamming distances39 between clone pairs were calculated into an adjacency matrix in Python, which was used to initiate a graph in igraph discarding edges weighted higher than distance 1. Cluster-associated functions in igraph were applied to discover independent clusters and to calculate associated PageRank scores24.

Clone orders and cluster diversity in Hill numbers. Without loss of generality, a clone with read count k was classified into order n if < ≤− −k2 2n n2 1. In each order clones with the same HBV status and vaccination history were pooled first. We defined clusters within each clone pool by an adjacency matrix, as described above. We then used Hill numbers, i.e. effective number of clusters in this case, to quantify cluster diversity. Pre- and post-vaccination cluster diversities in Hill numbers (D)23 were calculated following the formula with frequencies normalized in each order:

∑=

−( )D fC clusterf cluster frequencyq Hill number parameter

,,, (3)

q Cq q1/(1 )

The parameter q determines each measure’s sensitivity to normalized frequencies. The measure of =q 0 (the total diversity) counts clusters equally without regard to their normalized frequencies. The measure of =q 1 (Shannon diversity, the exponential of Shannon entropy40) counts clusters in proportional to their normalized frequencies, and thus can be interpreted as the number of common clusters in the data. The measure of =q 2 discounts all but the dominant clusters and can be interpreted as the number of dominant clusters in the data. The plot of Dq with respect to the parameter q is referred to as a “diversity profile” in ecological science. The profile is generally a decreasing function. The slope of the curve reflects the unevenness of cluster-normalized frequencies. The more uneven the distribution of normalized frequencies, the more steeply the curve declines. Graphs with =q (0, 5] were generated with igraph and Matplotlib (Fig. 4C; Supplementary Figs 3 and 5).

Cluster selection with support vector classification and logistic regression. Linear support vector classification and logistic regression from Scikit-learn were used to select clusters with “l1” penalties. Hellinger transformed frequencies served as independent variables for classification models. Penalties were chosen by min-imizing errors in 8-fold cross validations (Supplementary Fig. 2). In choosing clusters marking chronic HBV infections (Fig. 3), repertoires from carriers regardless of vaccination were labeled positive and penalty param-eter was set to 1,000. Carrier and non-carrier clone pools out of the 2-occurrence CDR-H3 sequences (Table 2) were used to define clusters with indicated adjacency matrices. The top 0.5% of clusters from both clone pools as ranked from high to low member counts were included for evaluation. In the case of picking clusters for vaccine responses (Fig. 5), only post-inoculation repertoires from non-carriers were labeled positive and the “l1” penalty parameter was set to 100. The most abundant 0.5% of non-carrier clusters in order 5 were statistically tested, which were identified from pooled clones of non-carriers independent of vaccination history. Significance in the children’s dataset was ascertained by random label permutations for 10,000 runs in each rarefaction, where chances of 4 or more clusters gaining dual strong support with all parameters higher than 20 were calculated. The 9 clusters from the adult dataset were derived using the same strategy.

References1. Wang, C. et al. B-cell repertoire responses to varicella-zoster vaccination in human identical twins. Proc Natl Acad Sci USA 112,

500–5 (2015).2. Chang, M. H. Hepatitis B virus infection. Semin Fetal Neonatal Med 12, 160–7 (2007).3. Jung, M. C. & Pape, G. R. Immunology of hepatitis B infection. Lancet Infect Dis 2, 43–50 (2002).4. Chang, M. H. et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan

Childhood Hepatoma Study Group. N Engl J Med 336, 1855–9 (1997).5. Dienstag, J. L., Stevens, C. E., Bhan, A. K. & Szmuness, W. Hepatitis B vaccine administered to chronic carriers of hepatitis b surface

antigen. Ann Intern Med 96, 575–9 (1982).6. Six, A. et al. The past, present, and future of immune repertoire biology - the rise of next-generation repertoire analysis. Front

Immunol 4, 413 (2013).7. Xu, J. L. & Davis, M. M. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13, 37–45

(2000).8. Lefranc, M. P. et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like

domains. Dev Comp Immunol 27, 55–77 (2003).9. Jiang, N. et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 5, 171ra19

(2013).10. Galson, J. D. et al. Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of

Vaccine-specific Antibody Sequences. EBioMedicine 2, 2070–9 (2015).11. Laserson, U. et al. High-resolution antibody dynamics of vaccine-induced immune responses. Proc Natl Acad Sci USA 111, 4928–33

(2014).12. Parameswaran, P. et al. Convergent antibody signatures in human dengue. Cell Host Microbe 13, 691–700 (2013).



13. Xiao, M., Prabakaran, P., Chen, W., Kessing, B. & Dimitrov, D. S. Deep sequencing and Circos analyses of antibody libraries reveal antigen-driven selection of Ig VH genes during HIV-1 infection. Exp Mol Pathol 95, 357–63 (2013).

14. Wang, C. et al. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires. J Immunol 192, 603–11 (2014).

15. Shi, W. et al. Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells. Nat Immunol 16, 663–73 (2015).

16. Shi, B. et al. Comparative analysis of human and mouse immunoglobulin variable heavy regions from IMGT/LIGM-DB with IMGT/HighV-QUEST. Theor Biol Med Model 11, 30 (2014).

17. Morisita, M. Measuring of the dispersion and analysis of distribution patterns, Memoires of the Faculty of Science, Series E. Biology, p215-235 (Kyushu University, 1959).

18. Legendre, P. & Gallagher, E. D. Ecologically Meaningful Transformations for Ordination of Species Data. Oecologia 129, 271–280 (2001).

19. Jolliffe, I. T. Principal component analysis, xxix, 487 p. (Springer, New York, 2002).20. Bashford-Rogers, R. J. et al. Network properties derived from deep sequencing of human B-cell receptor repertoires delineate B-cell

populations. Genome Res 23, 1874–84 (2013).21. Truck, J. et al. Identification of antigen-specific B cell receptor sequences using public repertoire analysis. J Immunol 194, 252–61

(2015).22. Pedregosa, F. et al. Scikit-learn: Machine Learning in Python. Journal of Machine Learning Research 12, 2825–2830 (2011).23. Hill, M. O. Diversity and evenness: a unifying notation and its consequences. Ecology 54, 427–432 (1973).24. Page, L., Brin, S., Motwani, R. & Winograd, T. The PageRank Citation Ranking: Bringing Order to the Web. (Stanford InfoLab, 1999).25. Glanville, J. et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human

immunoglobulin repertoire. Proc Natl Acad Sci USA 106, 20216–21 (2009).26. Cheung, W. C. et al. A proteomics approach for the identification and cloning of monoclonal antibodies from serum. Nat Biotechnol

30, 447–52 (2012).27. Greiff, V. et al. A bioinformatic framework for immune repertoire diversity profiling enables detection of immunological status.

Genome Med 7, 49 (2015).28. Zhang, J., Kobert, K., Flouri, T. & Stamatakis, A. PEAR: a fast and accurate Illumina Paired-End reAd mergeR. Bioinformatics 30,

614–20 (2014).29. Rossum, G. v. Python reference manual, ii, 54 p. (Centrum voor Wiskunde en Informatica, Amsterdam, The Netherlands, 1995).30. van der Walt, S., Colbert, S. C. & Varoquaux, G. The NumPy Array: A Structure for Efficient Numerical Computation. Computing in

Science & Engineering 13, 22–30 (2011).31. Pérez, F. & Granger, B. E. IPython: A System for Interactive Scientific Computing. Computing in Science & Engineering 9, 21–29

(2007).32. McKinney, W. Data Structures for Statistical Computing in Python. Proceedings of the 9th Python in Science Conference, Austin

Texas, 51–56. SciPy.org (http://conference.scipy.org/) (2010).33. Hunter, J. D. Matplotlib: A 2D Graphics Environment. Computing in Science & Engineering 9, 90–95 (2007).34. Klöckner, A. et al. PyCUDA and PyOpenCL: A scripting-based approach to GPU run-time code generation. Parallel Computing 38,

157–174 (2012).35. Csardi, G. & Nepusz, T. The igraph software package for complex network research. InterJournal Complex Systems, 1695 (2006).36. Giudicelli, V. et al. IMGT/LIGM-DB, the IMGT comprehensive database of immunoglobulin and T cell receptor nucleotide

sequences. Nucleic Acids Res 34, D781–4 (2006).37. Koressaar, T. & Remm, M. Enhancements and modifications of primer design program Primer3. Bioinformatics 23, 1289–91 (2007).38. Kircher, M., Sawyer, S. & Meyer, M. Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform.

Nucleic Acids Res 40, e3 (2012).39. Hamming, R. W. Error detecting and error correcting codes. Bell System Technical Journal 29, 147–160 (1950).40. Shannon, C. E. A Mathematical Theory of Communication. Bell System Technical Journal 27, 379–423 (1948).

AcknowledgementsThis work was supported by intramural grants of National Health Research Institutes (MG-102-PP-17, MG-103-PP-17, MG-104-PP-14, MG-105-PP-14). We thank Dr. Mei-Hui Chang at National Taiwan University Children Hospital for valuable suggestions.

Author ContributionsY.-H.C., C.-H.Y. and W.-B.H. prepared sequencing libraries. H.-C.K. assisted in recruiting attendants. T.C.H., K.H.M., A.C. and H.-H.L. analyzed the data. S.-F.T. and H.-H.L. designed the study. H.-H.L. wrote the manuscript and programmed the script.

Additional InformationSupplementary information accompanies this paper at http://www.nature.com/srepCompeting financial interests: The authors declare no competing financial interests.How to cite this article: Chang, Y.-H. et al. Network Signatures of IgG Immune Repertoires in Hepatitis B Associated Chronic Infection and Vaccination Responses. Sci. Rep. 6, 26556; doi: 10.1038/srep26556 (2016).

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license,

unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

http://conference.scipy.org/

http://www.nature.com/srep

http://creativecommons.org/licenses/by/4.0/

!

! 1!

Title&

Network!Signatures!of!IgG!Immune!Repertoires!in!Hepatitis!B!Associated!

Chronic!Infection!and!Vaccination!Responses!

&

Authors& &

Ya@Hui!Chang,!Hui@Chung!Kuan,!T.!C.!Hsieh,!K.!H.!Ma,!Chung@Hsiang!Yang,!

Wei@Bin!Hsu,!Shih@Feng!Tsai,!Anne!Chao,!&!Hong@Hsing!Liu!

&

Supplementary&Figure&and&Table&Legends&

Supplementary&Figure&1.!Overview&of&the&study&design,&construction&of&the&

immune&repertoires,&and&the&bioinformatic&pipeline&used&to&prepare&

CDRCH3&profiles&of&the&amino&acids.! ! (A)!Two!blood!samples!were!obtained!

from!the!children!and!three!from!the!adults!enrolled!in!the!study.! ! The!first!

sample!was!obtained!prior!to!receipt!of!the!HBV!vaccine;!the!second!sample!was!

2!weeks!later.! ! For!adults!an!additional!sample!at!1!week!after!vaccination!was!

collected.! ! (B)!1st@strand!cDNA!enriched!IgG!templates!with!a!primer!

hybridizing!specifically!to!the!constant!region.! ! The!PCR!was!followed!by!a!set!

of!forward!primers!targeting!various!V!exons!(V@primers)!and!universal!reversed!

primers.! ! 2nd!PCR!incorporated!double!indices!at!both!termini!and!P5/P7!

sequences!for!the!Illumina!platform.! ! (C)!Raw!reads!in!fastq!were!paired!first,!

and!those!with!ambiguous!‘N’!nucleotides!or!those!without!perfectly!matched!

terminal!sequences!to!PCR!primers!were!discarded.! ! CDR@H3!regions!were!

translatable!without!stop!codons!and!bridging!amino!acids!from!position!100!to!

C104!had!to!be!well!aligned!to!known!sequences.! ! Reads!without!the!

characteristic!W118!and!with!CDR@H3!lengths!shorter!than!2!amino!acids!were!

excluded.!

!

Supplementary&Figure&2.!Error&rates&in&8Cfold&or&2Cout&cross&validation&with&

“l1”&or&“l2”&penalties.! ! (ACB)!Error!rates!rapidly!declined!to!the!lowest!0.0625!

with!increasing!“l1”!penalties,!and!plateaued!after!penalty!parameters!passed!

1000!for!both!support!vector!classification!and!logistic!regression!models.! ! (CCD)!

Error!rates!with!“l2”!penalties!declined!slower!than!those!with!“l1”!penalties.! !

Plateaus!were!reached!when!penalty!parameters!surpassed!10,000!and!100,000!

!

! 2!

for!the!support!vector!classification!and!the!logistic!regression!models,!

respectively.!

!

Supplementary&Figure&3.!Diversity&profiles&of&CDRCH3&clusters&in&Hill&

numbers&for&clone&order&3C17&across&10&rarefaction&datasets&in&the&children.& &

(ACJ)!CDR@H3!clusters!connected!with!indel@free!Hamming!distance!1!were!

constructed!in!each!order!from!pooled!clones!with!the!same!infection!status!and!

vaccination!history.! ! Diversity!profiles!in!Hill!numbers!were!plotted!with!

parameters!ranging!from!0!to!5.! ! The!trends!with!vaccination!were!determined!

by!Hill!numbers!derived!from!parameter!2!and!above!such!that!abundant!

clusters!were!favored.! ! In!order!3,!4,!5,!9,!and!10!cluster!diversities!shifted!

distinctly!for!carriers!and!non@carriers.! ! Carriers!gained!a!positive!turn!only!in!

order!9!but!non@carriers!acquired!the!upward!momenta!in!all!other!4!orders.!

!

Supplementary&Figure&4.&Graphs&of&extended&clusters&associated&with&

vaccination.& & (A)&Two@step!extension!by!Hamming!distance!1!was!applied!to!

rarefaction@derived!6!clusters!in!children.! ! This!enriched!the!member!counts!to!

479,!346,!436,!705,!294,!and!849,!respectively.! ! (B)!9!clusters!related!to!

vaccination!response!in!adults!were!exhaustedly!enriched!in!two!steps!with!

clones!within!Hamming!distance!1!reach!to!make!new!clusters!containing!529,!

327,!523,!2577,!345,!286,!1474,!1144,!and!166!members,!respectively.!

!

Supplementary&Figure&5.&Diversity&profiles&of&CDRCH3&clusters&in&Hill&

numbers&for&clone&order&3C15&across&10&rarefaction&datasets&in&adults.& &

(ACJ)!In!each!order!pooled!CDR@H3!clones!from!the!same!timing!points!after!

vaccination!were!used!to!define!clusters!with!indel@free!Hamming!distance!1.! !

Diversity!profiles!in!Hill!numbers!were!plotted!with!parameters!ranging!from!0!

to!5.! ! The!baseline!Hill!numbers!with!parameter!0!were!always!much!higher!

than!after!vaccination.! ! In!order!5!the!2@week!curves!were!mostly!above!the!

baseline!curve!for!parameter!2!or!larger.!

!

Supplementary&Table&1.!Primer&sequences.& & List!of&oligonucleotides!used!in!

reverse!transcription,!repertoire!preparation,!and!index!incorporation.!

!

! 3!

!

Supplementary&Table&2.!Dissimilarities&between&samples&in&measures&of&

the&Morisita&Index.& & Values!closer!to!unity!in!the!sample!pairs!are!more!

dissimilar.! ! Similarities!are!color!coded!in!the!background!for!better!

visualization.! !

!

Supplementary&Table&3.!VaccinationCassociated&shifts&of&CDRCH3&cluster&

diversities&among&carrier&and&nonCcarrier&children&in&all&rarefaction&

datasets.! ! Those!with!increased!diversities!were!labeled!with!‘+’,!and!those!

with!decreased!diversities!were!marked!with!‘@‘.! ! The!final!determination!for!

each!order!was!averaged!across!all!datasets.! ! The!carriers!and!non@carriers!

were!distinctly!different!in!order!3,!4,!5,!9,!and!10!(shown!in!grey).!

!

Supplementary&Table&4.!Coefficients&of&both&support&vector&classification&

(SVC)&and&logistic&regression&(LR)&models&across&all&rarefaction&datasets&in&

children.! ! The!top!0.5%!of!non@carrier!clusters!with!higher!member!counts!

were!examined.! ! The!significant!leading!4!clusters!in!SVC!models!are!shown!in!

dark!grey!and!the!corresponding!LR!coefficients!are!shown!in!the!same!hue.! !

SVC!models!always!supported!4!clusters!strongly!with!occasional!minor!

inclusions!of!a!5th!cluster!(light!grey).! ! The!LR!models!agreed!with!SVC!models!

well!such!that!the!same!4!clusters!gained!the!highest!coefficient!values!nearly!in!

all!rarefactions.! ! Other!clusters!with!non@zero!values!in!LR!models!are!labeled!

in!light!grey.! ! In!both!models!there!were!no!clusters!beyond!the!top!0.3%!that!

had!coefficients!greater!than!zero.&

!

Supplementary&Table&5.!Sequences&of&six&CDRCH3&clusters&that&best&

signified&the&postCvaccination&samples&from&nonCcarrier&children.! ! The!

representative!sequences!with!the!highest!PageRank!scores!are!listed!above.! !

The!complete!sets!are!listed!at!the!bottom.! ! In!between!numbers!denoted!the!

ranks!from!high!to!low!in!the!SVC!models!for!each!rarefaction.! ! In!the!final!

dataset!the!secondly!supported!cluster!did!not!appear!in!other!datasets!and!was!

discarded.!

!

!

! 4!

Supplementary&Table&6.!Coefficients&of&both&support&vector&classification&

(SVC)&and&logistic&regression&(LR)&models&across&all&rarefaction&datasets&in&

the&adults.! ! The!top!0.5%!clusters!with!higher!member!counts!were!examined.! !

The!significant!leading!4!clusters!in!SVC!models!are!marked!in!dark!grey!and!the!

corresponding!LR!coefficients!are!shown!in!the!same!hue.! ! SVC!models!always!

strongly!supported!4!clusters!with!occasional!minor!inclusions!of!one!or!two!

other!clusters!(shown!in!light!grey).! ! LR!models!were!in!good!agreement!with!

SVC!models!such!that!the!same!4!clusters!gained!the!highest!coefficient!values!in!

all!rarefactions.! ! Other!clusters!with!non@zero!values!in!LR!models!are!labeled!

in!light!grey.! ! The!modeling!used!the!data!from!baselines!and!2@week!samples!

without!inclusions!of!the!data!from!1@week!samples.&

!

Supplementary&Table&7.!Sequences&of&nine&CDRCH3&clusters&that&best&

signified&the&postCvaccination&samples&in&adults.! ! The!representative!

sequences!with!the!highest!PageRank!scores!are!listed!above,!and!the!complete!

sets!are!listed!at!the!bottom.! ! The!in!between!numbers!denote!the!ranks!from!

high!to!low!in!the!SVC!models!for!each!rarefaction.!

!

A�

2 weeks�

Children�1st� 2nd�

Vaccination�

B�

V� D� J� C�

1st PCR�

2nd PCR�

1st strand cDNA�

C�

Fastq� No ‘N’�Read 1/2 Pairing�

Read2 Start Seq. Correct�

Read1 Start Seq. Correct�

CDR3 Length Equals 3n�

No Stop Codons�

Aligned to V Exons�

Trp 118 Present�

CDR3 ≥ 2 Amino Acids� CDR3 Profile for Analyses�

Supplementary,Fig.,1�

1 week�

1st� 2nd�

1 week�

3rd�

Adult�

A� B�

Penalty Parameter

Err

or R

ates

in 2

-Out

Cro

ss V

alid

atio

n�

penalty = “l1”

Linear Support Vector Classification

penalty = “l2”

C�

Logistic Regression

penalty = “l1”

penalty = “l2”

D�


A�

B�

� � � �

� ��

��

��

Order�

� � � �

� ��

��

��

Order�

Hill$Num

ber$D

iversity�

Hill$Number$Parameter$q�

Hill$Num

ber$D

iversity�



C�

D

� � � �

� ��

��

��

Order�

� � � �

� ��

��

��

Order�

Hill$Num

ber$D

iversity�


Hill$Num

ber$D

iversity�


E�

F�

� � � �

� ��

��

��

Order�

� � � �

� ��

��

��

Order�

Hill$Num

ber$D

iversity�


Hill$Num

ber$D

iversity�


G�

H�

� � � �

� ��

��

��

Order�

� � � �

� ��

��

��

Order�

Hill$Num

ber$D

iversity�


Hill$Num

ber$D

iversity�


I�

J�

� � � �

� ��

��

��

Order�

� � � �

� ��

��

��

Order�

Hill$Num

ber$D

iversity�


Hill$Num

ber$D

iversity�


Supplementary,Fig.,4�A�

AKGDGQNYFDYSGMDV$� AKRASTIAVRLYYFDF$�

ARVLTASMVRGVIIGNYYYGMDV$� AKDSQGWFGNLLNYFDQ$�

ARDTGSSWYTNWFDP$� AREGYEFSMDV$�

B�

ARDNRGLGDS$� ARDLVRSSSSFDL$� ARWRGMNFWSGYYFDY$�

VRDRCSTSCYHGEY$� ARDIQRTGDY$� ASAPYGGYPD$�

ATGGYSYGLNQY$� ARDPYSSGWPVGYYMDV$� ATSSGWSY$�

Hill$Num

ber$D

iversity�


A�


Order��

� ��

��

��

Hill$Num

ber$D

iversity�


B�

Order��

� ��

��

��

Hill$Num

ber$D

iversity�


C�

Order��

� ��

��

��

Hill$Num

ber$D

iversity�


D�

Order��

� ��

��

��

Hill$Num

ber$D

iversity�


E�

Order��

� ��

��

��

Hill$Num

ber$D

iversity�


F�

Order��

� ��

��

��

Hill$Num

ber$D

iversity�


G�

Order��

� ��

��

��

Hill$Num

ber$D

iversity�


H�

Order��

� ��

��

��

Hill$Num

ber$D

iversity�


I�

Order��

� ��

��

��

Hill$Num

ber$D

iversity�


J�

Order��

� ��

��

��

GAGTTCCACGACACCGTCACC Primer for reverse transcription

GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCCAGGGGGAAGACCGATGGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCCAGGGGGAAGACGGATGG

ACACTCTTTCCCTACACGACGCTCTTCCGATCTACAGCCTACATGGAGCTGAGCAACACTCTTTCCCTACACGACGCTCTTCCGATCTACATCCACGAGCACAGCCTACATACACTCTTTCCCTACACGACGCTCTTCCGATCTCACAGACCTGAGCAGCCTGACACACTCTTTCCCTACACGACGCTCTTCCGATCTGACACGTCCACGAGCACAGTCTAACACTCTTTCCCTACACGACGCTCTTCCGATCTCCAAAAACCAGGTGGTCCTTACAACACTCTTTCCCTACACGACGCTCTTCCGATCTCTCCAAAAGCCAGGTGGTCCTACACTCTTTCCCTACACGACGCTCTTCCGATCTAACAGCCTGAGAGCCGAGGACACACTCTTTCCCTACACGACGCTCTTCCGATCTCGCCAAGAACTCCCTGTATCTGACACTCTTTCCCTACACGACGCTCTTCCGATCTTGCCAAGAACTCCTTGTATCTTCAACACTCTTTCCCTACACGACGCTCTTCCGATCTCACGCTGTATCTGCAAATGAACACACTCTTTCCCTACACGACGCTCTTCCGATCTAAAACACGCTGTATCTGCAAATGATACACTCTTTCCCTACACGACGCTCTTCCGATCTGAACAGACGGAGAGCCGAGGAACACTCTTTCCCTACACGACGCTCTTCCGATCTTTCCTGTATCAGCAAATGAACAGCACACTCTTTCCCTACACGACGCTCTTCCGATCTAGTCTGAGAGCCGAGGACACGACACTCTTTCCCTACACGACGCTCTTCCGATCTGCCAAGAACACACTTCATCTGCAAACACTCTTTCCCTACACGACGCTCTTCCGATCTGAACAGGCTGTATCTGCAAATGAACACACTCTTTCCCTACACGACGCTCTTCCGATCTCCAAGAACACGCTGTATCTGCAAACACTCTTTCCCTACACGACGCTCTTCCGATCTAATAGCCTGAGGGCCGAGGACACACTCTTTCCCTACACGACGCTCTTCCGATCTTTCAAATGAACAACCTGAGAGCTGAACACTCTTTCCCTACACGACGCTCTTCCGATCTCAAGAACACGCTGCATCTTCAAAACACTCTTTCCCTACACGACGCTCTTCCGATCTGCAAAAACTCCCTGTATCTGCAAACACTCTTTCCCTACACGACGCTCTTCCGATCTTGAACAGCCTGATAGCTGAGGAACACTCTTTCCCTACACGACGCTCTTCCGATCTTGAACAGCCTGAGAGACGAGGAACACTCTTTCCCTACACGACGCTCTTCCGATCTTCCAAAAGCATCGCCTATCTGCACACTCTTTCCCTACACGACGCTCTTCCGATCTCCAAGAACACGCTGTATCTTCAAATGACACTCTTTCCCTACACGACGCTCTTCCGATCTGACAATTCCAAGAACACGCTGTATACACTCTTTCCCTACACGACGCTCTTCCGATCTAAGAACTCACTGTATCTGCAAATGAACACACTCTTTCCCTACACGACGCTCTTCCGATCTCGGCGTATCTGCAAATGAACAACACTCTTTCCCTACACGACGCTCTTCCGATCTGCCAAGAACACGCTGTATCTGCACACTCTTTCCCTACACGACGCTCTTCCGATCTTCCCTGAAGCTGAGCTCTGTGACACACTCTTTCCCTACACGACGCTCTTCCGATCTCCTGAAGCCGAGCTCTGTGACACACTCTTTCCCTACACGACGCTCTTCCGATCTTCAGTAGACACGTCCAAGAACCAGACACTCTTTCCCTACACGACGCTCTTCCGATCTACGTCTAAGAACCAGTTCTCCCTGAACACTCTTTCCCTACACGACGCTCTTCCGATCTACGTCCAAGAACCAGTTCTACCTGAACACTCTTTCCCTACACGACGCTCTTCCGATCTCCTGAAGCTGAGCTCTGTGACCACACTCTTTCCCTACACGACGCTCTTCCGATCTTGCCTACCTGCAGTGGAGCAGACACTCTTTCCCTACACGACGCTCTTCCGATCTTCCCTGCAGCTGAACTCTGTGACACTCTTTCCCTACACGACGCTCTTCCGATCTCCTCTGTCAGCACGGCATATCACACTCTTTCCCTACACGACGCTCTTCCGATCTCACCTCTGTCAGCATGGCATATCACACTCTTTCCCTACACGACGCTCTTCCGATCTCAGCACGGCGTGTCTTCAGATACACTCTTTCCCTACACGACGCTCTTCCGATCTTCTGCCAGCACAGCATACCTG

AATGATACGGCGACCACCGAGATCTACACCCTGCGAACACTCTTTCCCTACACGACGCTCTT AATGATACGGCGACCACCGAGATCTACACTGCAGAGACACTCTTTCCCTACACGACGCTCTT AATGATACGGCGACCACCGAGATCTACACACCTAGGACACTCTTTCCCTACACGACGCTCTT AATGATACGGCGACCACCGAGATCTACACTTGATCCACACTCTTTCCCTACACGACGCTCTT AATGATACGGCGACCACCGAGATCTACACATCTTGCACACTCTTTCCCTACACGACGCTCTT AATGATACGGCGACCACCGAGATCTACACTCTCCATACACTCTTTCCCTACACGACGCTCTT AATGATACGGCGACCACCGAGATCTACACCATCGAGACACTCTTTCCCTACACGACGCTCTT AATGATACGGCGACCACCGAGATCTACACTTCGAGCACACTCTTTCCCTACACGACGCTCTT AATGATACGGCGACCACCGAGATCTACACAGTTGGTACACTCTTTCCCTACACGACGCTCTT AATGATACGGCGACCACCGAGATCTACACGTACCGGACACTCTTTCCCTACACGACGCTCTT

CAAGCAGAAGACGGCATACGAGATGAAGATTGTGACTGGAGTTCAGACGTGT CAAGCAGAAGACGGCATACGAGATCGTTGGTGTGACTGGAGTTCAGACGTGT CAAGCAGAAGACGGCATACGAGATGCCATCTGTGACTGGAGTTCAGACGTGT CAAGCAGAAGACGGCATACGAGATAACCTGGGTGACTGGAGTTCAGACGTGT CAAGCAGAAGACGGCATACGAGATCTAACGGGTGACTGGAGTTCAGACGTGT CAAGCAGAAGACGGCATACGAGATAGAGGCGGTGACTGGAGTTCAGACGTGT CAAGCAGAAGACGGCATACGAGATCCGCAAGGTGACTGGAGTTCAGACGTGT CAAGCAGAAGACGGCATACGAGATCTCCGCCGTGACTGGAGTTCAGACGTGT CAAGCAGAAGACGGCATACGAGATACGTCCAGTGACTGGAGTTCAGACGTGT CAAGCAGAAGACGGCATACGAGATCATGGTTGTGACTGGAGTTCAGACGTGT

Primers paired with V-primers

V-primers

P5 primers with indices 1-10

P7 primers with indices 1-10

Supplementary,Table,1�

F1Cpre

F1Cpost

F2Cpre

F2Cpost

F3Cpre

F3Cpost

F4Cpre

F4Cpost

F1NCpre

F1NCpost

F2NCpre

F2NCpost

F3NCpre

F3NCpost

F4NCpre

F4NCpost

F1Cpre

-0.9520422

0.99736840.9999285

0.99759940.9992634

0.99988890.9998626

0.99986980.9987032

0.99802890.9996612

0.99999160.9999925

0.99989390.9994598

F1Cpost

0.9520422-

0.99970430.9998895

0.99996490.9985481

0.99991710.9999760

0.99998160.9999852

0.99996930.9999869

0.99998910.9999996

0.99996950.9999952

F2Cpre

0.99736840.9997043

-0.9564328

0.99999780.9998627

0.99622310.9996804

0.99933940.9986972

0.99835870.9986251

0.99999530.9999936

0.99990180.9999466

F2Cpost

0.99992850.9998895

0.9564328-

0.99999880.9998897

0.99919030.9986955

0.99997590.9999754

0.99999100.9999994

0.99989290.9999518

0.99999120.9999959

F3Cpre

0.99759940.9999649

0.99999780.9999988

-0.9600126

0.99997740.9998113

0.99998220.9999474

0.99999170.9999999

0.99993660.9998646

0.99740710.9999963

F3Cpost

0.99926340.9985481

0.99986270.9998897

0.9600126-

0.99994320.9999724

0.99873600.9995761

0.99985320.9999522

0.99989760.9999813

0.99999930.9999992

F4Cpre

0.99988890.9999171

0.99622310.9991903

0.99997740.9999432

-0.9498923

0.99998060.9999953

0.99996240.9999958

0.99996110.9999377

0.99387260.9997232

F4Cpost

0.99986260.9999760

0.99968040.9986955

0.99981130.9999724

0.9498923-

0.99998140.9999089

0.99998110.9999958

0.99994400.9999465

0.99462370.9996588

F1NCpre

0.99986980.9999816

0.99933940.9999759

0.99998220.9987360

0.99998060.9999814

-0.9125702

0.99969090.9999769

0.99978830.9994165

0.99998320.9999794

F1NCpost

0.99870320.9999852

0.99869720.9999754

0.99994740.9995761

0.99999530.9999089

0.9125702-

0.99952350.9998812

0.99971510.9994518

0.99996620.9999668

F2NCpre

0.99802890.9999693

0.99835870.9999910

0.99999170.9998532

0.99996240.9999811

0.99969090.9995235

-0.9165187

0.99986430.9996570

0.99629390.9999327

F2NCpost

0.99966120.9999869

0.99862510.9999994

0.99999990.9999522

0.99999580.9999958

0.99997690.9998812

0.9165187-

0.99981380.9999755

0.99931150.9948752

F3NCpre

0.99999160.9999891

0.99999530.9998929

0.99993660.9998976

0.99996110.9999440

0.99978830.9997151

0.99986430.9998138

-0.9563739

0.99995810.9999984

F3NCpost

0.99999250.9999996

0.99999360.9999518

0.99986460.9999813

0.99993770.9999465

0.99941650.9994518

0.99965700.9999755

0.9563739-

0.99994870.9999995

F4NCpre

0.99989390.9999695

0.99990180.9999912

0.99740710.9999993

0.99387260.9946237

0.99998320.9999662

0.99629390.9993115

0.99995810.9999487

-0.9945914

F4NCpost

0.99945980.9999952

0.99994660.9999959

0.99999630.9999992

0.99972320.9996588

0.99997940.9999668

0.99993270.9948752

0.99999840.9999995

0.9945914-

Supplementary,Table,2�Similar,

Dissimilar,


3 4 5 6 7 8 9 10 11 12 13 14 15 16 17- - ± - - - + - - + + + + ± +

1 - - + - - - + - - + + + + ± +2 + - - - - - + - - + + + + ± +3 - - - - - - + - - + + + + ± +4 - - + - - - + - - + + + + ± +5 - - + - - - + - - + + + + ± +6 - + - - - - + - - + + + + ± +7 - - - - - - + - - + + + + ± +8 - - + - - - + - - + + + + ± +9 - - - - - - + - - + + + + ± +10 + - + - - - + - - + + + + ± +

+ + + - - - - + - + + + + - -1 + + + - - - - + - + + + + - -2 + + + - - - - + - + + + + - -3 + + + - - - - + - + + + + - -4 + + + - - - - + - + + + + - -5 + + + - - - - + - + + + + - -6 + - + - - - - + - + + + + - -7 + + + - - - - + - + + + + - -8 + + + - - - - + - + + + + - -9 + + + - - - - + - + + + + - -10 + + + - - - - + - + + + + - -

OrderCarriers

Non-carriers

Rare

fact

ion

Rare

fact

ion

� � � � � � ��

� ��

� ��

� ��

� ��

��

��

� ��

� ��

��

��

� ��

� ��

� ��

� ��

��

��

� ��

� ��

��

��

� ��

� ��

� ��

� ��

� ��

��

��

� ��

� ��

��

��

� ��

� ��

� ��

� ��

��

��

� ��

� ��

��

��

� � � � � � � � � � � � � ��

� ��

� ��

� ��

� ��

��

��

� ��

� ��

��

��

� ��

� ��

� ��

� ��

��

��

� ��

� ��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��


AKGDGQNYFDYSGMDV AKRASTIAVRLYYFDF ARVLTASMVRGVIIGNYYYGMDV AKDSQGWFGNLLNYFDQ ARDTGSSWYTNWFDP AREGYEFSMDV� 1 - 2 3 4 -� - 1 3 2 4 -� 1 - 3 4 - 2� - 1 2 3 - 4� - 1 3 2 - 4� 1 - 2 3 - 4� - 1 3 2 4 - 1 - 2 3 - 4 1 - 2 3 4 -�� - 1 3 - 4 -

AKGDCQNYFDYSGMDV AIRASTIAVRLYYFDF AGVLTASMVRGVIIGNYYYGMDV AEDSQGWFGNLLNYFDY AGDTGSSWYTNWFDP AGEGYEFSMDVAKGDGHNYFDYSGMDV AKMASTIAVRLYYFDF ARALTASMVRGVIIGNYYYGMDV AIDSQGWFGNLLNYFDQ AIDTGSSWYTNWFDP ARDGYEFSMDVAKGDGKNYFDYSGMDV AKRAATIAVRLYYFDF ARDLTASMVRGVIIGNYYYGMDV AIDSQGWFGNLLNYFDY ARATGSSWYTNWFDP AREAYDFSMDVAKGDGLNYFDYSGMDV AKRASTIAARLYYFDF ARFLTASMVRGVIIGNYYYGMDV AKASQGWFGNLLNYFDQ ARDAGSSWYTNWFDP AREDYDFSMDVAKGDGQIYFDYSGMDV AKRASTIAFRLYYFDF ARVLAASMVRGVIIGNYYYGMDV AKDFQGWFGNLLNYFDQ ARDKGSSWYTNWFDP AREEYDFSMDVAKGDGQNFFDYSGMDV AKRASTIAGRLYYFDF ARVLTAAMVRGVIIGNYYYGMDV AKDPQGWFGNLLNYFDQ ARDTCSSWYTNWFDP AREEYEFSMDVAKGDGQNYFAYSGMDV AKRASTIAVLLYYFDF ARVLTASLVRGVIIGNYYYGMDV AKDSHGWFGNLLNYFDY ARDTGCSWYTNWFDP AREGCEFSMDVAKGDGQNYFDFSGMDV AKRASTIAVPLYYFDF ARVLTASMVLGVIIGNYYYGMDV AKDSLGWFGNLLNYFDQ ARDTGGSWYTNWFDP AREGDDFSLDAAKGDGQNYFDYCGMDV AKRASTIAVRIYYFDF ARVLTASMVQGVIIGNYYYGMDV AKDSLGWFGNLLNYFDY ARDTGISWYTNWFDP AREGDEFSMDVAKGDGQNYFDYSCMDV AKRASTIAVRLNYFDF ARVLTASMVRGVIIGDYYYGMDV AKDSQGCFGNLLNYFDQ ARDTGSCWYTNWFDP AREGFDFSLDAAKGDGQNYFDYSGIDV AKRASTIAVRLYNFDF ARVLTASMVRGVIIGIYYYGMDV AKDSQGWCGNLLNYFDQ ARDTGSIWYTNWFDP AREGNDFSLDAAKGDGQNYFDYSGMAV AKRASTIAVRLYYFDF ARVLTASMVRGVIIGNCYYGMDV AKDSQGWFENLLNYFDQ ARDTGSNWYTNWFDP AREGYDFSLAAAKGDGQNYFDYSGMDA AKRASTIAVRLYYFDS ARVLTASMVRGVIIGNYCYGMDV AKDSQGWFGDLLNYFDQ ARDTGSRWYTNWFDP AREGYDFSLDAAKGDGQNYFDYSGMDG AKRASTIAVRLYYFGF ARVLTASMVRGVIIGNYFYGMDV AKDSQGWFGILLNYFDY ARDTGSSWDTNWFDP AREGYDFSLDSAKGDGQNYFDYSGMDV AKRASTIAVRLYYFVF ARVLTASMVRGVIIGNYHYGMDV AKDSQGWFGKLLNYFDQ ARDTGSSWFTNWFDP AREGYDFSLVAAKGDGQNYFDYSGMVV AKRASTIAVRLYYFYF ARVLTASMVRGVIIGNYYNGMDV AKDSQGWFGNFLNYFDQ ARDTGSSWNTNWFDP AREGYEFSLDAAKGDGQNYFDYSGMYV AKRASTIAVRLYYIDF ARVLTASMVRGVIIGNYYYCMDV AKDSQGWFGNILNYFDQ ARDTGSSWYTKWFDP AREGYEFSMDAAKGDGQNYFDYSVMDV AKRASTIAVRLYYLDF ARVLTASMVRGVIIGNYYYGIDV AKDSQGWFGNILNYFDY ARDTGSSWYTNCFDP AREGYEFSMDLAKGDGQNYFDYYGMDV AKRASTIAVRQYYFDF ARVLTASMVRGVIIGNYYYGLDV AKDSQGWFGNLFNYFDQ ARDTGSSWYTNWFDL AREGYEFSMDVAKGDGQNYFVYSGMDV AKRASTIAVSLYYFDF ARVLTASMVRGVIIGNYYYGMDA AKDSQGWFGNLINYFDQ ARDTGSSWYTNWFDP AREGYEFSMYVAKGDGQNYIDYSGMDV AKRASTIEVRLYYFDF ARVLTASMVRGVIIGNYYYGMDD AKDSQGWFGNLLDYFDQ ARDTGSSWYTNWFDT AREGYEISMDVAKGDGQNYLDYSGMDV AKRASTISVRLYYFDF ARVLTASMVRGVIIGNYYYGMDG AKDSQGWFGNLLKYFDQ ARDTGSSWYTNWFVP AREGYELSMDVAKGDVQNYFDYSGMDV AKRASTKAVRLYYFDF ARVLTASMVRGVIIGNYYYGMDV AKDSQGWFGNLLNFFDQ ARDTGSSWYTNWFYP AREGYEYSMDVAKGEGQNYFDYSGMDV AKRASTMAVRLYYFDF ARVLTASMVRGVIIGNYYYGMEV AKDSQGWFGNLLNNFDQ ARDTGSSWYTSWFDP AREGYNFSMDVAKGNGQNYFDYSGMDV AKRDSTIAVRLYYFDF ARVLTASMVRGVIIGNYYYGMGV AKDSQGWFGNLLNYFAQ ARDTGSSWYTTWFDP AREGYVFSLDAAKGVGQNYFDYSGMDV AKRTSTIAVRLYYFDF ARVLTASMVRGVIIGNYYYGMVV AKDSQGWFGNLLNYFDE ARDTVSSWYTNWFDP ARERYDFSMDVAKVDGQNYFDYSGMDV ANRASTIAVRLYYFDF ARVLTASMVRGVIIGNYYYGMYV AKDSQGWFGNLLNYFDQ ARETGSSWYTNWFDP ARERYEFSMDVARGDCQNYFDYSGMDV EKRASTIAVRLYYFDF ARVLTASMVRGVIIGNYYYGVDV AKDSQGWFGNLLNYFDR ARGTGSSWYTNWFDP ARESYDFSMDVARGDGLNYFDYSGMDV SKRASTIAVRLYYFDF ARVLTASMVRGVIIGNYYYSMDV AKDSQGWFGNLLNYFDS ARVTGSSWYTNWFDP AREVYDFSLDAARGDGQNYFDYSGIDV ARVLTASMVRGVIIGNYYYVMDV AKDSQGWFGNLLNYFEQ ARYTGSSWYTNWFDP AREWYEFSMDVARGDGQNYFDYYGMDV ARVLTASMVRGVIIGSYYYGMDV AKDSQGWFGNLLNYFEY ASDTGSSWYTNWFDP ARVGYDFSLDAARGDVQNYFDYSGMDV ARVLTASMVRGVIIGYYYYGMDV AKDSQGWFGNLLNYFGQ SRDTGSSWYTNWFDP ARVGYEFSMDVSKGDGQNYFDYSGMDV ARVLTASMVRGVIIVNYYYGMDV AKDSQGWFGNLLNYFGY VRDTGSSWYTNWFDP ASEGYEFSMDV

ARVLTASMVRGVIIWNYYYGMDV AKDSQGWFGNLLNYFVQ EREGYEFSMDVARVLTASMVRGVINGNYYYGMDV AKDSQGWFGNLLNYFVY SREGYEFSMDVARVLTASMVRGVTIGNYYYGMDV AKDSQGWFGNLLNYFYQARVLTASMVRRVIIGNYYYGMDV AKDSQGWFGNLLNYFYYARVLTASTVRGVIIGNYYYGMDV AKDSQGWFGNLLNYIDQARVLTSSMVRGVIIGNYYYGMDV AKDSQGWFGNLLSYFDQARVMTASMVRGVIIGNYYYGMDV AKDSQGWFGSLLNYFDQARVQTASMVRGVIIGNYYYGMDV AKDSQGWFGSLLNYFDYERVLTASMVRGVIIGNYYYGMDV AKDSQGWFGYLLNYFDQSRVLTASMVRGVIIGNYYYGMDV AKDSQGWFRNLLNYFDQ

AKDSQGWFRNLLNYFDYAKDSQGWSGNLLNYFDQAKDSQGWYGNLLNYFDQAKDSQRWFGNLLNYFDQAKDSRGWFGNLLNYFDQAKDTQGWFGNLLNYFDQAKDYQGWFGNLLNYFDQAKESQGWFGNLLNYFDQAKESQGWFGNLLNYFDYAKGSQGWFGNLLNYFDQAKYSQGWFGNLLNYFDQANDSQGWFGNLLNYFDYEKDSQGWFGNLLNYFDQPKDSQGWFGNLLNYFDQVKDSQGWFGNLLNYFDQ

Rarefac'on�



� � � � � � ��

� ��

� ��

� ��

� ��

��

��

� ��

� ��

� ��

��

� ��

� ��

� ��

� ��

� ��

��

� ��

� ��

��

��

� ��

� ��

� ��

� ��

� ��

��

��

� ��

� ��

��

��

� ��

� ��

� ��

� ��

��

��

� ��

� ��

��

��

� � � � � � � �

� ��

� ��

� ��

� ��

��

��

� ��

� ��

��

��

� ��

� ��

� ��

� ��

��

��

� ��

� ��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

��

Supplementary,Table,7�ARDNRGLGDS ARDLVRSSSSFDL ARWRGMNFWSGYYFDY VRDRCSTSCYHGEY ARDIQRTGDY ASAPYGGYPD ATGGYSYGLNQY ARDPYSSGWPVGYYMDV ATSSGWSY

� 1 2 3 4 - - - - -� - 2 3 4 1 - - - -� 1 - 2 - - 3 4 - -� 1 - 3 - - 4 - 2 -� 1 - 3 - - 4 - 2 -� - - 2 4 1 3 - - -� - - 2 4 - 3 - - 1 1 - 2 4 - 3 - - - 1 - 2 4 - 3 - - -�� 1 - 3 - - 4 - 2 -

AGDNRGLGDS AGDLVRSSSSFDL AKWRGMNFWSGYYFDY AGDRCSTSCYHAEY AGDIHRTGDY ACAPYGGYPD AIGGYSYGLNQY AGDPYSSGWPVGYFMDV AASSGWSYAIDNRGLGDS ARDFVRSSSSFDL ARRRGMNFWSGYYFDY AGDRCSTSCYHGEY AGDIQRTGDY AIAPYGGYPD ASGGYSYGLNQH AGDPYSSGWPVGYYMDV ASSSGWSYARANRGLGDS ARDLGRSSSSFDL ARWPGMNFWSGYYFDY AIDRCSTSCYHGEY AIDIHRTGDY ANAPYGGYPD ASGGYSYGLNQY AIDPYSSGWPLGYFMDV ATCSGWSYARDDRGLGDS ARDLVPSSSSFDL ARWRAMNFWSGYYFDY ARDRCCTGCYHGEY AIDIQRTGDY ASAPCGGYPD ATCGYSYGLNQY AIDPYSSGWPVGYFMDV ATSRGWSYARDHRGLGDS ARDLVRCSSSFDL ARWRGLNFWSGYYFDY ARDRCCTSCYHCEY AKDIHRTGDY ASAPHGGYPD ATDGYSYGLNQY AIDPYSSGWPVGYYMDV ATSSGRSYARDNCGLGDS ARDLVRGSSSFDL ARWRGMDFWSGYYFDY ARDRCCTSCYHVEY ARDIDRTGDY ASAPYGGNPD ATGEYSYGLNQY AKDPYSSGWPLGYFMDV ATSSGWSYARDNEGLGDN ARDLVRNSSSFDL ARWRGMHFWSGYYFDY ARDRCSISCYHGEY ARDIERTGDY ASAPYGGYPA ATGGCSYGLNHY ARDAYSSGWPVGYFMDV ATSSGWYYARDNEGLGDQ ARDLVRSCSSFDL ARWRGMNFGSGYYFDY ARDRCSTACYHGEY ARDIHLTGDY ASAPYGGYPD ATGGCSYGLSHY ARDLYSSGWPVGYYMDV TTSSGWSYARDNEGLGDS ARDLVRSNSSFDL ARWRGMNFSSGYYFDY ARDRCSTGCYHGEY ARDIHRPGDY ASAPYGGYPE ATGGGSYGLNHY ARDPCSSGWPVGYYMDVARDNEGLGDY ARDLVRSSSCFDL ARWRGMNFWCGYYFDY ARDRCSTSCCHGEY ARDIHRSGDY ASAPYGGYPG ATGGHSYGLNQY ARDPFSSGWPVGYFMDVARDNGGLGDS ARDLVRSSSFFDL ARWRGMNFWNGYYFDY ARDRCSTSCFHCEY ARDIHRTCDY ASAPYGGYPY ATGGLSYGLNHY ARDPNSSGWPVGYYMDVARDNPGLGDS ARDLVRSSSSFDL ARWRGMNFWSAYYFDY ARDRCSTSCFHVEY ARDIHRTGDY ASAPYGRYPD ATGGLSYGLSHY ARDPYCSGWPVGYFMDVARDNRDLGDS ARDLVRSSSSFEL ARWRGMNFWSGSYFDY ARDRCSTSCHHGEY ARDIHRTGGY ASAPYGSYPD ATGGNSYGLNHY ARDPYCSGWPVGYYMDVARDNRGLADS ARDLVRSSSSFNL ARWRGMNFWSGYCFDY ARDRCSTSCYHCEY ARDIHRTGYY ASAPYSGYPD ATGGNSYGLNQY ARDPYGSGWPLGYFMDVARDNRGLEDS ARDLVRSSSSSDL ARWRGMNFWSGYFFDY ARDRCSTSCYHGEY ARDIKRTGDY ASDPYGGYPD ATGGSSYGLNQY ARDPYGSGWPVGYFMDVARDNRGLGDC ARDLVRSSSSVDL ARWRGMNFWSGYHFDY ARDRCSTSCYNGEY ARDINRTGDY ASPPYGGYPD ATGGYGYGLNQY ARDPYGSGWPVGYYMDVARDNRGLGDF ARDLVRSSSSYDL ARWRGMNFWSGYSFDY ARDRCSTSFFHGEY ARDIPRTGDY ATAPYGGYPD ATGGYNYGLNQY ARDPYISGWPLGYFMDVARDNRGLGDS ARDLVRSSSYFDL ARWRGMNFWSGYYFAY ARDRCSTSRYHGEY ARDIQLTGDY ESAPYGGYPD ATGGYSCGLNQY ARDPYSCGWPVGYFMDVARDNRGLGES ARDLVRSSWSFDL ARWRGMNFWSGYYFDY ARDRFSTSCYHGEY ARDIQRAGDY GSAPYGGYPD ATGGYSFGLNQY ARDPYSCGWPVGYYMDVARDNRGLGNS ARDRVRSSSSFDL ARWRGMNFWSGYYFNY ARERCSTSCYHGEY ARDIQRIGDY PSAPYGGYPD ATGGYSHGLNQY ARDPYSIGWPVGYFMDVARDNRGLGVS ARGLVRSSSSFDL ARWRGMNFWSGYYFVY ARYRCSTSCYHGEY ARDIQRKGDY TSAPYGGYPD ATGGYSSGLNQY ARDPYSIGWPVGYYMDVARDNRGLGYS ARNLVRSSSSFDL ARWRGMNFWSGYYYDY ERDRCCTTCYHGEY ARDIQRPGDY ATGGYSYGLHQY ARDPYSSDWPVGYYMDVARDNRGLRDS ARYLVRSSSSFDL ARWRGMNFWTGYYFDY ERDRCSSSCYHGEH ARDIQRRGDY ATGGYSYGLNEH ARDPYSSGRPLGYFMDVARDNRGWGDS GRDLVRSSSSFDL ARWRGMNSWSGYYFDY ERDRCSTSCYHAEY ARDIQRTGDF ATGGYSYGLNEY ARDPYSSGRPVGYFMDVARDNRRLGDS PRDLVRSSSSFDL ARWRGMNVWSGYYFDY GRDRCSTSCYHGEY ARDIQRTGDH ATGGYSYGLNHH ARDPYSSGRPVGYYMDVARDNRSLGDS TRDLVRSSSSFDL ARWRGMNYWSGYYFDY LRDRCCTTCYHGEY ARDIQRTGDY ATGGYSYGLNKH ARDPYSSGSPVGYFMDVARDNSGLGDS ATWRGMNFWSGYYFDY LRDRCSSSCYHGEH ARDIQRTGGY ATGGYSYGLNPY ARDPYSSGSPVGYYMDVARDSRGLGDS GRWRGMNFWSGYYFDY LRDRCSTSCYHGEH ARDIQRTGYY ATGGYSYGLNQC ARDPYSSGWAVGYFMDVARDYRGLGDS PRWRGMNFWSGYYFDY LRDRCSTSCYHGEY ARDLHRTGDY ATGGYSYGLNQD ARDPYSSGWAVGYYMDVARENRGLGDS MRDRCCTTCYHGEY ARDMHRTGDY ATGGYSYGLNQQ ARDPYSSGWHVGYFMDVARVNRGLGDS MRDRCSSSCYHGEH ARDVQRTGDY ATGGYSYGLNQS ARDPYSSGWPAGYFMDVARYNRGLGDS MRDRCSTSCYHGEY ARGIQRTGDY ATGGYSYGLNQY ARDPYSSGWPAGYYMDVASDNRGLGDS SRDRCSTSCYHAEY ARYIQRTGDY ATGGYSYGLNRY ARDPYSSGWPEGYFMDVATDNRGLGDS SRDRCSTSCYHGEY ERDIQRTGDY ATGGYSYGLYQY ARDPYSSGWPLGYFIDVDRDNRGLGDS TRDRCSTSCYHGEY SRDIHRTGDY ATGGYSYRLNQH ARDPYSSGWPLGYFLDVGRDNRGLGDS VGDRCSTSCYHGEH SRDIQRTGDY ATGGYSYWLNQH ARDPYSSGWPLGYFMEVPRDNRGLGDS VGDRCSTSCYHGEY TRDIQRTGDY ATGGYSYWLNQY ARDPYSSGWPLGYYMDVSRDNRGLGDS VMDRCCTTCYHGEY VRDIQRTGDY ATGGYTYGLNQY ARDPYSSGWPLRYFMDVTRDNRGLGDS VRARCSSSCYHGEH ATGRYSYGLNQH ARDPYSSGWPLSYFMDV

VRARCSTSCYHGEH ATGRYSYGLNQY ARDPYSSGWPLVYFMDVVRARCSTSCYHGEY ATGVYSYGLNQH ARDPYSSGWPMGYFMDVVRDGCSSSCYHGEH ATGVYSYGLNQN ARDPYSSGWPMGYYMDVVRDLCSSSCYHGEY ATGVYSYGLNQY ARDPYSSGWPVCYFMDVVRDLCSTSCFHGEY ATSGYSYGLNQY ARDPYSSGWPVCYYMDVVRDLCSTSCYHGEY GTGGYSYGLNQY ARDPYSSGWPVGFYMDVVRDQCCTTCYHGEY PTGGYSYGLNQY ARDPYSSGWPVGHFMDVVRDQCSSSCYHGEH STCGNSYGLNQY ARDPYSSGWPVGHYMDVVRDQCSTSCYHGEY TAGGYSYGLNQY ARDPYSSGWPVGYCMDVVRDRCCSSCYHGEH TPGGYSYGLNQY ARDPYSSGWPVGYFLDVVRDRCCTACYHGEY TSGGYSYGLNQH ARDPYSSGWPVGYFMDAVRDRCCTSCYHGEY TSGGYSYGLNQY ARDPYSSGWPVGYFMDFVRDRCCTTCCHGEY TTCGNSYGLNQY ARDPYSSGWPVGYFMDVVRDRCCTTCSHGEY TTCGYSYGLNQY ARDPYSSGWPVGYFMEVVRDRCCTTCYDGEY TTGAYSYGLNQY ARDPYSSGWPVGYFMGVVRDRCCTTCYHGEF TTGEYSYGLNQY ARDPYSSGWPVGYFMYVVRDRCCTTCYHGEY TTGGCSYGLNQY ARDPYSSGWPVGYHMDVVRDRCCTTCYHGKY TTGGFSYGLNQY ARDPYSSGWPVGYSMDVVRDRCCTTCYHGQY TTGGNSYRLNQY ARDPYSSGWPVGYYIDVVRDRCCTTCYHGVY TTGGNSYVLNQY ARDPYSSGWPVGYYMDAVRDRCCTTCYLGEY TTGGYGYGLNQY ARDPYSSGWPVGYYMDFVRDRCCTTCYYGEY TTGGYNYGLNQY ARDPYSSGWPVGYYMDGVRDRCCTTFYHGEY TTGGYSFGLNQY ARDPYSSGWPVGYYMDVVRDRCGSSCYHGEH TTGGYSYGLHQY ARDPYSSGWPVGYYMGVVRDRCGTTCYHGEY TTGGYSYGLNHH ARDPYSSGWPVGYYMVVVRDRCITSCYHGEH TTGGYSYGLNPY ARDPYSSGWPVGYYMYVVRDRCNSSCYHGEH TTGGYSYGLNQC ARDPYSSGWPVGYYVDVVRDRCNTSCYHGEY TTGGYSYGLNQD ARDPYSSGWPVRYYMDVVRDRCRTTCYHGEY TTGGYSYGLNQF ARDPYSSGWPVSYFMDVVRDRCSASCYHGEY TTGGYSYGLNQQ ARDPYSSGWSVGYFMDVVRDRCSGSCYHGEH TTGGYSYGLNQY ARDPYSSGWTLGYFMDVVRDRCSPSCYHGEY TTGGYSYGLNRY ARDPYSSGWTVGYFMDVVRDRCSRSCYHGEH TTGGYSYGPNQY ARDPYSTGWPVGYYMDVVRDRCSSCCYHGEH TTGGYSYGRNQY ARDRYSSGWPVGYFMDVVRDRCSSICYHGEH TTGGYSYRLNQY ARDRYSSGWPVGYYMDVVRDRCSSSCCHGEH TTGGYSYVLNQY ARDSYSSGWPVGYYMDVVRDRCSSSCDHGEH TTGGYSYWLNQH AREPYSSGWPLGYFMDVVRDRCSSSCFHGEH TTGGYSYWLNQY ARGPYSSGWPLGYFMDVVRDRCSSSCYHAEH TTGGYTYGLNQY ARGPYSSGWPVGYFMDVVRDRCSSSCYHDEH TTGRNSYGLNQY ARYPYSSGWPVGYFMDVVRDRCSSSCYHGDH TTGRYSYGLNQH ARYPYSSGWPVGYYMDVVRDRCSSSCYHGEH TTGRYSYGLNQY ASDPYSSGWPVGYFMDVVRDRCSSSCYHGER TTGVNSYGLNQY ASDPYSSGWPVGYYMDVVRDRCSSSCYHGQH TTGVYSYGLNQH GRDPYSSGWPVGYYMDVVRDRCSSSCYHGVH TTSGNSYGLNQY TRDPYSSGWPVGYFMDVVRDRCSSSCYHREH TTSGYSYGLNQY VRDPYSSGWPVGYFMDVVRDRCSSSCYHSEH VTGGYSYGLNQYVRDRCSSSCYHVEHVRDRCSSSCYLGEHVRDRCSSSCYYGEHVRDRCSSSGYHGEHVRDRCSSSSYHGEHVRDRCSSSYYHGEHVRDRCSSTCYHGEHVRDRCSTACYHGEFVRDRCSTACYHGERVRDRCSTACYHGESVRDRCSTGCYHGECVRDRCSTGCYHGEHVRDRCSTGCYHGEYVRDRCSTICYHGEHVRDRCSTNCYHGEYVRDRCSTRCYHGEHVRDRCSTRCYHGEYVRDRCSTSCDHGEYVRDRCSTSCFHCEYVRDRCSTSCFHGDYVRDRCSTSCFHSDYVRDRCSTSCLHGEYVRDRCSTSCSHGEYVRDRCSTSCYDGEHVRDRCSTSCYDGEYVRDRCSTSCYHGDHVRDRCSTSCYHGDYVRDRCSTSCYHGEHVRDRCSTSCYHGELVRDRCSTSCYHGENVRDRCSTSCYHGESVRDRCSTSCYHGEYVRDRCSTSCYHGGYVRDRCSTSCYHGQYVRDRCSTSCYHREYVRDRCSTSCYHVEYVRDRCSTSCYLGEHVRDRCSTSCYLGEYVRDRCSTSCYNGEHVRDRCSTSCYNGEYVRDRCSTSCYQGEHVRDRCSTSCYRGEYVRDRCSTSCYYGEHVRDRCSTSFFHGEYVRDRCSTSFYHGEHVRDRCSTSFYHGEYVRDRCSTSGYHGEYVRDRCSTSRYHGEYVRDRCSTSSYHGEHVRDRCSTSWYHGEYVRDRCSTTCYHGECVRDRCSTTCYHGEYVRDRCSTVCYHGECVRDRCTSSCYHGEHVRDRCYTTCYHGEYVRDRFSTSCYHGEHVRDRFSTSCYHGEYVRDRGSSSCYHGEHVRDRRSSSCYHGEHVRDRRSTSCYHGEHVRDRRSTSCYHGEYVRDRSSTSCYHGEHVRDRYSSSCYHGEHVRDRYSTSCYHGEHVRDRYSTSCYHGEYVRDWCSTSCYHGEYVRERCCTTCYHGEYVRGRCCTTCYHGEYVRGRCSSSCYHGEHVRGRCSTSCYHGEHVRHRCCTTCYHGEYVRNRCCTTCYHGEYVRNRCSSSCYHGEHVRVRCSSSCYHGEHVSDRCCTTCYHGEYVSDRCSSSCYHGEHVSDRCSTSCYHGEY

network signatures of igg immune repertoires in hepatitis

Documents